Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepatic Function

Clinical trial NCT06911320 · COMPLETED

Trial details

NCT number: NCT06911320
Sponsor: Atea Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteer Study Hepatic Impairment Renal Impairment

Start date: 2025-04-09
Primary completion: 2026-04-30
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.